 | UZ9 | Name: | (2S)-2-AMINO-6-({(4R)-4-[(10R,13S)-10,13-DIMETHYL-3-OXOHEXADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL]PENTANOYL}AMINO)HEXANOIC ACID | Formula: | C30 H50 N2 O4 | SMILES: | O=C(O)C(N)CCCCNC(=O)CCC(C1CCC2C1(C)CCC4C2CCC3CC(=O)CCC34C)C | InChi: | InChI=1S/C30H50N2O4/c1-19(7-12-27(34)32-17-5-4-6-26(31)28(35)36)23-10-11-24-22-9-8-20-18-21(33)13-15-29(20,2)25(22)14-16-30(23,24)3/h19-20,22-26H,4-18,31H2,1-3H3,(H,32,34)(H,35,36)/t19-,20-,22+,23-,24+,25+,26+,29+,30-/m1/s1 | Definition date: | 2004-03-08 | Last modified: | 2024-09-27 | Identifier: | N~6~-[(5beta,14beta,17alpha)-3,24-dioxocholan-24-yl]-L-lysine |
|
 | UZA | Name: | (2S,6E)-2-amino-2-methylnon-6-enoic acid | Formula: | C10 H19 N O2 | SMILES: | NC(C(=O)O)(C)CCCC=CCC | InChi: | InChI=1S/C10H19NO2/c1-3-4-5-6-7-8-10(2,11)9(12)13/h4-5H,3,6-8,11H2,1-2H3,(H,12,13)/b5-4+/t10-/m0/s1 | Definition date: | 2020-06-08 | Last modified: | 2024-09-27 | Release date: | 2020-07-22 | Identifier: | (2S,6E)-2-amino-2-methylnon-6-enoic acid |
|
 | 6A0 | Name: | (2S)-2-amino-8-(hydroxyamino)-8-oxooctanoic acid | Formula: | C8 H16 N2 O4 | SMILES: | NC(C(O)=O)CCCCCC(NO)=O | InChi: | InChI=1S/C8H16N2O4/c9-6(8(12)13)4-2-1-3-5-7(11)10-14/h6,14H,1-5,9H2,(H,10,11)(H,12,13)/t6-/m0/s1 | Definition date: | 2016-02-24 | Last modified: | 2024-09-27 | Release date: | 2016-05-11 | Identifier: | (2S)-2-amino-8-(hydroxyamino)-8-oxooctanoic acid |
|
 | UZM | Name: | (3S)-3-(2,4-dichlorophenyl)-N~1~-hydroxy-N~5~-(3-sulfanylpropyl)pentanediamide | Formula: | C14 H18 Cl2 N2 O3 S | SMILES: | c1c(cc(c(c1)C(CC(NO)=O)CC(=O)NCCCS)Cl)Cl | InChi: | InChI=1S/C14H18Cl2N2O3S/c15-10-2-3-11(12(16)8-10)9(7-14(20)18-21)6-13(19)17-4-1-5-22/h2-3,8-9,21-22H,1,4-7H2,(H,17,19)(H,18,20)/t9-/m0/s1 | Definition date: | 2020-06-09 | Last modified: | 2024-09-27 | Release date: | 2020-09-23 | Identifier: | (3S)-3-(2,4-dichlorophenyl)-N~1~-hydroxy-N~5~-(3-sulfanylpropyl)pentanediamide |
|
 | 6A8 | Name: | ((R)-1-((S)-3-(4-(aminomethyl)phenyl)-2-benzamidopropaneamido)-4-guanidinobutyl)boronic acid, cyclic double ester with glycerol | Formula: | C25 H35 B N6 O5 | SMILES: | O=C(NC(Cc1ccc(cc1)CN)C(NC(B2OC(CO)CO2)CCCN/C(N)=N)=O)c3ccccc3 | InChi: | InChI=1S/C25H35BN6O5/c27-14-18-10-8-17(9-11-18)13-21(31-23(34)19-5-2-1-3-6-19)24(35)32-22(7-4-12-30-25(28)29)26-36-16-20(15-33)37-26/h1-3,5-6,8-11,20-22,33H,4,7,12-16,27H2,(H,31,34)(H,32,35)(H4,28,29,30)/t20-,21-,22-/m0/s1 | Definition date: | 2016-02-25 | Last modified: | 2024-09-27 | Release date: | 2016-12-14 | Identifier: | 4-(aminomethyl)-Nalpha-(benzenecarbonyl)-N-{(1R)-4-carbamimidamido-1-[(4S)-4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl]butyl}-L-phenylalaninamide |
|
 | UZS | Name: | N-hydroxy-7-sulfanylheptanamide | Formula: | C7 H15 N O2 S | SMILES: | ONC(CCCCCCS)=O | InChi: | InChI=1S/C7H15NO2S/c9-7(8-10)5-3-1-2-4-6-11/h10-11H,1-6H2,(H,8,9) | Definition date: | 2020-06-09 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | N-hydroxy-7-sulfanylheptanamide |
|
 | UZV | Name: | N-hydroxy-5-sulfanylpentanamide | Formula: | C5 H11 N O2 S | SMILES: | C(CCCCS)(NO)=O | InChi: | InChI=1S/C5H11NO2S/c7-5(6-8)3-1-2-4-9/h8-9H,1-4H2,(H,6,7) | Definition date: | 2020-06-09 | Last modified: | 2024-09-27 | Release date: | 2020-09-23 | Identifier: | N-hydroxy-5-sulfanylpentanamide |
|
 | UZY | Name: | N-hydroxy-6-sulfanylhexanamide | Formula: | C6 H13 N O2 S | SMILES: | C(CCCCCS)(NO)=O | InChi: | InChI=1S/C6H13NO2S/c8-6(7-9)4-2-1-3-5-10/h9-10H,1-5H2,(H,7,8) | Definition date: | 2020-06-09 | Last modified: | 2024-09-27 | Release date: | 2020-09-23 | Identifier: | N-hydroxy-6-sulfanylhexanamide |
|
 | 6AO | Name: | (2S)-2-azanyl-N-[(2S)-1-azanylidene-3-(4-phenylphenyl)propan-2-yl]butanamide | Formula: | C19 H23 N3 O | SMILES: | O=C(NC(C=[N@H])Cc1ccc(cc1)c2ccccc2)C(N)CC | InChi: | InChI=1S/C19H23N3O/c1-2-18(21)19(23)22-17(13-20)12-14-8-10-16(11-9-14)15-6-4-3-5-7-15/h3-11,13,17-18,20H,2,12,21H2,1H3,(H,22,23)/b20-13+/t17-,18-/m0/s1 | Definition date: | 2013-10-31 | Last modified: | 2024-09-27 | Release date: | 2014-03-19 | Identifier: | (2S)-2-amino-N-[(2S,3E)-1-(biphenyl-4-yl)-3-iminopropan-2-yl]butanamide |
|
 | 6AZ | Name: | 6-azidouridine 5'-(dihydrogen phosphate) | Formula: | C9 H12 N5 O9 P | SMILES: | [N-]=[N+]=NC=1N(C(=O)NC(=O)C=1)C2OC(C(O)C2O)COP(=O)(O)O | InChi: | InChI=1S/C9H12N5O9P/c10-13-12-4-1-5(15)11-9(18)14(4)8-7(17)6(16)3(23-8)2-22-24(19,20)21/h1,3,6-8,16-17H,2H2,(H,11,15,18)(H2,19,20,21)/t3-,6-,7-,8-/m1/s1 | Synonyms: | 6-AZIDO-UMP | Definition date: | 2009-02-16 | Last modified: | 2024-09-27 | Identifier: | 6-azidouridine 5'-(dihydrogen phosphate) |
|
 | V0G | Name: | N-(3-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)-4-{[4-(dimethylamino)butanoyl]amino}benzamide | Formula: | C31 H30 Cl N7 O2 | SMILES: | c1c(ccc(c1)NC(=O)CCCN(C)C)C(=O)Nc2cccc(c2)Nc3nc(c(Cl)cn3)c4c5c(nc4)cccc5 | InChi: | InChI=1S/C31H30ClN7O2/c1-39(2)16-6-11-28(40)35-21-14-12-20(13-15-21)30(41)36-22-7-5-8-23(17-22)37-31-34-19-26(32)29(38-31)25-18-33-27-10-4-3-9-24(25)27/h3-5,7-10,12-15,17-19,33H,6,11,16H2,1-2H3,(H,35,40)(H,36,41)(H,34,37,38) | Definition date: | 2020-06-10 | Last modified: | 2024-09-27 | Release date: | 2020-09-09 | Identifier: | N-(3-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)-4-{[4-(dimethylamino)butanoyl]amino}benzamide |
|
 | 6B7 | Name: | (2~{R},3~{R},4~{R})-4-methyl-3-(2-oxidanylidene-2-propoxy-ethyl)sulfanyl-5-[(2~{S},3~{R})-3-oxidanyl-1-oxidanylidene-butan-2-yl]-3,4-dihydro-2~{H}-pyrrole-2-carboxylic acid | Formula: | C15 H23 N O6 S | SMILES: | CCCOC(=O)CS[CH]1[CH](C)C(=N[CH]1C(O)=O)[CH](C=O)[CH](C)O | InChi: | InChI=1S/C15H23NO6S/c1-4-5-22-11(19)7-23-14-8(2)12(10(6-17)9(3)18)16-13(14)15(20)21/h6,8-10,13-14,18H,4-5,7H2,1-3H3,(H,20,21)/t8-,9-,10-,13+,14-/m1/s1 | Definition date: | 2016-03-01 | Last modified: | 2024-09-27 | Release date: | 2016-10-05 | Identifier: | (2~{R},3~{R},4~{R})-4-methyl-3-(2-oxidanylidene-2-propoxy-ethyl)sulfanyl-5-[(2~{S},3~{R})-3-oxidanyl-1-oxidanylidene-butan-2-yl]-3,4-dihydro-2~{H}-pyrrole-2-carboxylic acid |
|
 | 6B8 | Name: | (2S,3R,4R)-2-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-3-methyl-4-(methylsulfanyl)-3,4-dihydro-2H-pyrrole-5-carboxylic acid | Formula: | C11 H17 N O4 S | SMILES: | OC(C=1C(C(C(C(C(O)C)C=O)N=1)C)SC)=O | InChi: | InChI=1S/C11H17NO4S/c1-5-8(7(4-13)6(2)14)12-9(11(15)16)10(5)17-3/h4-8,10,14H,1-3H3,(H,15,16)/t5-,6-,7-,8-,10-/m1/s1 | Definition date: | 2016-03-01 | Last modified: | 2024-09-27 | Release date: | 2016-10-12 | Identifier: | (2S,3R,4R)-2-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-3-methyl-4-(methylsulfanyl)-3,4-dihydro-2H-pyrrole-5-carboxylic acid |
|
 | 6B9 | Name: | 2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)-5-[(E)-(sulfanylmethylidene)amino]benzoic acid | Formula: | C21 H13 N O5 S | SMILES: | O=C(O)c1cc(N=[C@H]S)ccc1C2=C4C(Oc3c2ccc(c3)O)=CC(=O)C=C4 | InChi: | InChI=1S/C21H13NO5S/c23-12-2-5-15-18(8-12)27-19-9-13(24)3-6-16(19)20(15)14-4-1-11(22-10-28)7-17(14)21(25)26/h1-10,23H,(H,22,28)(H,25,26) | Definition date: | 2016-03-01 | Last modified: | 2024-09-27 | Release date: | 2017-03-08 | Identifier: | 2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)-5-[(E)-(sulfanylmethylidene)amino]benzoic acid |
|
 | V0Q | Name: | [4-(4-ethylpiperazin-1-yl)sulfonylphenyl]methanol | Formula: | C13 H20 N2 O3 S | SMILES: | CCN1CCN(CC1)[S](=O)(=O)c2ccc(CO)cc2 | InChi: | InChI=1S/C13H20N2O3S/c1-2-14-7-9-15(10-8-14)19(17,18)13-5-3-12(11-16)4-6-13/h3-6,16H,2,7-11H2,1H3 | Definition date: | 2021-04-01 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | [4-(4-ethylpiperazin-1-yl)sulfonylphenyl]methanol |
|
 | V0T | Name: | 1-[4-(hydroxymethyl)phenyl]sulfonylpiperidin-4-ol | Formula: | C12 H17 N O4 S | SMILES: | OCc1ccc(cc1)[S](=O)(=O)N2CCC(O)CC2 | InChi: | InChI=1S/C12H17NO4S/c14-9-10-1-3-12(4-2-10)18(16,17)13-7-5-11(15)6-8-13/h1-4,11,14-15H,5-9H2 | Definition date: | 2021-04-01 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 1-[4-(hydroxymethyl)phenyl]sulfonylpiperidin-4-ol |
|
 | 6BH | Name: | N-[3-(benzyloxy)phenyl]-3-nitrobenzamide | Formula: | C20 H16 N2 O4 | SMILES: | O=[N+]([O-])c1cccc(c1)C(=O)Nc2cccc(c2)OCc3ccccc3 | InChi: | InChI=1S/C20H16N2O4/c23-20(16-8-4-10-18(12-16)22(24)25)21-17-9-5-11-19(13-17)26-14-15-6-2-1-3-7-15/h1-13H,14H2,(H,21,23) | Definition date: | 2015-09-24 | Last modified: | 2024-09-27 | Release date: | 2016-09-21 | Identifier: | N-[3-(benzyloxy)phenyl]-3-nitrobenzamide |
|
 | 6BI | Name: | [(2~{R},3~{S},4~{R},5~{R})-5-[6-(ethylamino)purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate | Formula: | C18 H28 Cl N6 O8 P | SMILES: | O[CH]1[CH](O)[CH](O[CH]1CO[P](O)(O)=O)n2cnc3c(NCCCCCCNC(=O)CCl)ncnc23 | InChi: | InChI=1S/C18H28ClN6O8P/c19-7-12(26)20-5-3-1-2-4-6-21-16-13-17(23-9-22-16)25(10-24-13)18-15(28)14(27)11(33-18)8-32-34(29,30)31/h9-11,14-15,18,27-28H,1-8H2,(H,20,26)(H,21,22,23)(H2,29,30,31)/t11-,14-,15-,18-/m1/s1 | Definition date: | 2021-07-26 | Last modified: | 2024-09-27 | Release date: | 2022-06-01 | Identifier: | [(2~{R},3~{S},4~{R},5~{R})-5-[6-[6-(2-chloranylethanoylamino)hexylamino]purin-9-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate |
|
 | V0W | Name: | 1-methyl-4-(4-methylphenyl)sulfonyl-1,4-diazepane | Formula: | C13 H20 N2 O2 S | SMILES: | CN1CCCN(CC1)[S](=O)(=O)c2ccc(C)cc2 | InChi: | InChI=1S/C13H20N2O2S/c1-12-4-6-13(7-5-12)18(16,17)15-9-3-8-14(2)10-11-15/h4-7H,3,8-11H2,1-2H3 | Definition date: | 2021-04-01 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 1-methyl-4-(4-methylphenyl)sulfonyl-1,4-diazepane |
|
 | 6BR | Name: | threoninevanadate | Formula: | C4 H8 N O7 V | SMILES: | NC(C(O[V]([O-])(=O)([O-])[O-])C)C(O)=O | InChi: | InChI=1S/C4H8NO3.4O.V/c1-2(6)3(5)4(7)8 | Definition date: | 2016-03-03 | Last modified: | 2024-09-27 | Release date: | 2016-06-15 | Identifier: | trioxido(oxo)(L-threoninato-kappaO~3~)vanadate(3-) |
|
 | V1A | Name: | S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-imidazol-4-yl) methanesulfonothioate | Formula: | C8 H15 N2 O3 S2 | SMILES: | ON1C(C(SS(=O)(=O)C)=NC1(C)C)(C)C | InChi: | InChI=1S/C8H16N2O3S2/c1-7(2)6(14-15(5,12)13)9-8(3,4)10(7)11/h11H,1-5H3 | Definition date: | 2009-11-09 | Last modified: | 2024-09-27 | Identifier: | S-(1-hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-imidazol-4-yl) methanesulfonothioate |
|
 | V1C | Name: | (2S)-2-azanyl-3-[4-[1-(2-methylpropyl)pyrazol-4-yl]phenyl]propanoic acid | Formula: | C16 H21 N3 O2 | SMILES: | CC(C)Cn1cc(cn1)c2ccc(C[CH](N)C(O)=O)cc2 | InChi: | InChI=1S/C16H21N3O2/c1-11(2)9-19-10-14(8-18-19)13-5-3-12(4-6-13)7-15(17)16(20)21/h3-6,8,10-11,15H,7,9,17H2,1-2H3,(H,20,21)/t15-/m0/s1 | Definition date: | 2023-07-03 | Last modified: | 2024-09-27 | Release date: | 2023-11-01 | Identifier: | (2~{S})-2-azanyl-3-[4-[1-(2-methylpropyl)pyrazol-4-yl]phenyl]propanoic acid |
|
 | 6C1 | Name: | {2-[(3-chlorophenyl)methoxy]phenyl}boronic acid | Formula: | C13 H12 B Cl O3 | SMILES: | c1(c(cccc1)OCc2cccc(Cl)c2)B(O)O | InChi: | InChI=1S/C13H12BClO3/c15-11-5-3-4-10(8-11)9-18-13-7-2-1-6-12(13)14(16)17/h1-8,16-17H,9H2 | Definition date: | 2016-03-08 | Last modified: | 2024-09-27 | Release date: | 2017-03-15 | Identifier: | {2-[(3-chlorophenyl)methoxy]phenyl}boronic acid |
|
 | V1E | Name: | ~{N},~{N},4-trimethylbenzenesulfonamide | Formula: | C9 H13 N O2 S | SMILES: | CN(C)[S](=O)(=O)c1ccc(C)cc1 | InChi: | InChI=1S/C9H13NO2S/c1-8-4-6-9(7-5-8)13(11,12)10(2)3/h4-7H,1-3H3 | Definition date: | 2021-04-06 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | ~{N},~{N},4-trimethylbenzenesulfonamide |
|
 | V1H | Name: | 3-methoxy-1-(4-methylphenyl)sulfonyl-azetidine | Formula: | C11 H15 N O3 S | SMILES: | COC1CN(C1)[S](=O)(=O)c2ccc(C)cc2 | InChi: | InChI=1S/C11H15NO3S/c1-9-3-5-11(6-4-9)16(13,14)12-7-10(8-12)15-2/h3-6,10H,7-8H2,1-2H3 | Definition date: | 2021-04-06 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 3-methoxy-1-(4-methylphenyl)sulfonyl-azetidine |
|